We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$257M
AUM Growth
-$13.3M
Cap. Flow
-$15.3M
Cap. Flow %
-5.95%
Top 10 Hldgs %
43.17%
Holding
259
New
67
Increased
65
Reduced
68
Closed
57

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.62M
2
MCD icon
McDonald's
MCD
+$2.54M
3
MDLZ icon
Mondelez International
MDLZ
+$2.52M
4
CI icon
Cigna
CI
+$2.32M
5
JPM icon
JPMorgan Chase
JPM
+$2.18M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Financials 13.15%
3 Healthcare 9.82%
4 Consumer Discretionary 6.3%
5 Industrials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$789B
$42.5M 16.51%
78,100
-4,200
-5% -$2.2M
IWM icon
2
PUT
iShares Russell 2000 ETF
IWM
$79.9B
$38.8M 15.05%
191,000
-25,200
-12% -$5.09M
WFC icon
3
Wells Fargo
WFC
$261B
$5.06M 1.96%
85,157
+42,910
+102% +$2.53M
MS icon
4
Morgan Stanley
MS
$331B
$4.49M 1.74%
46,207
+23,387
+102% +$2.23M
AAPL icon
5
Apple
AAPL
$4.43T
$4.31M 1.68%
20,483
+6,785
+50% +$1.27M
MSFT icon
6
Microsoft
MSFT
$3.43T
$4.14M 1.61%
9,268
-6,192
-40% -$2.62M
WMT icon
7
Walmart Inc
WMT
$888B
$3.41M 1.32%
50,377
+8,620
+21% +$543K
ABBV icon
8
AbbVie
ABBV
$444B
$3.01M 1.17%
17,549
+5,437
+45% +$901K
BAC icon
9
Bank of America
BAC
$435B
$2.92M 1.13%
73,307
+13,958
+24% +$535K
JPM icon
10
JPMorgan Chase
JPM
$939B
$2.57M 1%
12,713
-11,151
-47% -$2.18M
NVDA icon
11
NVIDIA
NVDA
$4.82T
$2.54M 0.99%
20,575
+5
+0% +$506
TXN icon
12
Texas Instruments
TXN
$252B
$2.32M 0.9%
11,951
+6,005
+101% +$1.11M
CL icon
13
Colgate-Palmolive
CL
$72.8B
$2.32M 0.9%
+23,939
New +$2.21M
SCHW
14
Charles Schwab
SCHW
$183B
$2.28M 0.89%
30,988
+12,973
+72% +$958K
VZ icon
15
Verizon
VZ
$195B
$2.28M 0.89%
55,330
+4,853
+10% +$196K
CVX icon
16
Chevron
CVX
$391B
$2.24M 0.87%
14,352
+6,504
+83% +$1.04M
XOM icon
17
ExxonMobil
XOM
$641B
$2.21M 0.86%
19,221
+234
+1% +$27.3K
UNP icon
18
Union Pacific
UNP
$173B
$2.2M 0.86%
9,741
-341
-3% -$79.9K
SPYG icon
19
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51.6B
$2.16M 0.84%
26,966
+18,379
+214% +$1.37M
PM icon
20
Philip Morris
PM
$298B
$2.11M 0.82%
20,826
-1,337
-6% -$131K
CB icon
21
Chubb
CB
$135B
$2.07M 0.8%
8,117
-8,437
-51% -$2.17M
KVUE icon
22
Kenvue
KVUE
$37.1B
$2.06M 0.8%
113,567
+26,453
+30% +$513K
ANET icon
23
Arista Networks
ANET
$227B
$2.06M 0.8%
23,544
+2,088
+10% +$155K
MRK icon
24
Merck
MRK
$322B
$2.05M 0.8%
16,566
-7,034
-30% -$906K
ELV icon
25
Elevance Health
ELV
$81.7B
$2.05M 0.8%
3,778
-220
-6% -$116K

Similar funds

Alpha DNA Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Alpha DNA Investment Management held 259 positions worth $257M, down 4.9% from $271M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Alpha DNA Investment Management withdrew a net $15.3M in Q2 2024, closing 57 positions and reducing 68 holdings. Its most notable exit was Cigna, an estimated $2.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Alpha DNA Investment Management opened a new position in Colgate-Palmolive worth $2.32M.

  • Alpha DNA Investment Management's largest Q2 2024 buy was Colgate-Palmolive: 23,939 shares worth $2.32M.
  • Alpha DNA Investment Management added most to Wells Fargo in Q2 2024, an estimated $2.53M increase.
  • Alpha DNA Investment Management's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.62M.
  • Alpha DNA Investment Management fully exited Cigna in Q2 2024, selling an estimated $2.32M.
  • Alpha DNA Investment Management's ten largest holdings make up 43% of its $257M portfolio in Q2 2024.
  • Alpha DNA Investment Management opened 67 new positions and closed 57 in Q2 2024.
  • Alpha DNA Investment Management's portfolio value fell 4.9% quarter-over-quarter to $257M.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.